Peer-reviewedCC BY-NCActa dermato-venereologica2 Nov 2026

Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience.

Mariá Simas D'Aquino¹
Roberto Moreira Amorim Filho²
Gustavo Moreira Amorim²

¹Santa Teresa Dermatology Sanitary Hospital, São Pedro de Alcântara, Brazil; South Santa Catarina University - School of Medicine., Palhoça, Brazil. [email protected].
²Santa Teresa Dermatology Sanitary Hospital, São Pedro de Alcântara, Brazil.

Inflammatory Bowel Disease Patients’ Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience
Clotilde Remy, Bénédicte Caron, Celia Gouynou +5
Journal of Clinical Medicine4 Sep 2026Peer-reviewedCC BY 4.0Full text29 citedGenetics & genomicsHAL
Lived experience of patients following eye enucleation: a phenomenological study in western Iran
Raheleh Rasad, Alireza Khatony, Amir Jalali +5
Scientific Reports27 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textGenetics & genomicsCrossref
Experience-dependent shifts in behavioural decision-making following repeated captures in a wild mammal
Fragkiskos Darmis, Yiannis G. Zevgolis
Royal Society Open Science21 Oct 2026Peer-reviewedCC BY 4.0Full textEcologyCrossrefEurope PMC
Comparing prescribing and spending across originator, follow-on, and interchangeable biosimilar insulin glargine: Opportunities to improve uptake of biosimilar medications
Lucille M. Abrams, Kylee Funk, Joel F. Farley
Journal of Managed Care & Specialty Pharmacy1 Nov 2026Peer-reviewedLicence not statedFull textImmunologyPMC
Women’s experience following orthodontic treatment with conventional fixed appliances and clear aligners: A qualitative study
Nicolle San Nicolas Dubrull Lia Lucarelli, Gabriela Gonçalves Innocente, Pedro Augusto Thiene Leme +5
PLOS One2 Nov 2026Peer-reviewedCC BYFull textGeneral biology Epidemiology & public healthPLOSEurope PMCPMC

Cite

BibTeX

@article{daquino2026clinical,
  title = {{Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience.}},
  author = {Mariá Simas D'Aquino and Roberto Moreira Amorim Filho and Gustavo Moreira Amorim},
  journal = {Acta dermato-venereologica},
  year = {2026},
  month = nov,
  doi = {10.2340/actadv.v106.adv-2026-0624},
  url = {https://europepmc.org/article/MED/42969559},
  note = {CC BY-NC},
}

RIS

TY  - JOUR
TI  - Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience.
AU  - Mariá Simas D'Aquino
AU  - Roberto Moreira Amorim Filho
AU  - Gustavo Moreira Amorim
PY  - 2026
DA  - 2026/11/02
JO  - Acta dermato-venereologica
DO  - 10.2340/actadv.v106.adv-2026-0624
UR  - https://europepmc.org/article/MED/42969559
SN  - 0001-5555
SN  - 1651-2057
ER  -

Related

Cite